An increased tumor-infiltrating CD4+ T-cell count and an increased CD4+:CD8+ T-cell ratio have been demonstrated to be significantly associated with improved patient response to BCG156 in athymic nude mice168. This evidence concerns the gene CD8A and neoplasm.